Exercise suppresses COX-2 pro-inflammatory pathway in vestibular migraine

Brain Research Bulletin

Volumn 116, Issue , 2015, Pages 98-105

  Lee, Yi Yen ^a,b   Yang, Yi Ping ^a   Huang, Pin I ^a,b   Li, Wen Cheng ^c   Huang, Ming Chao ^a,b   Kao, Chung Lan ^a,b   Chen, Yann Jang ^a,d   Chen, Ming Teh ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

Cyclooxygenase 2 (COX 2); Exercise; Migraine; Vestibular

Indexed keywords

CYCLOOXYGENASE 2; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; MALONALDEHYDE; MESSENGER RNA; NOS2 PROTEIN, HUMAN; PTGS2 PROTEIN, HUMAN;

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DIZZINESS; ENZYME ACTIVITY; FEMALE; HUMAN; IMMUNE SYSTEM; INFLAMMATION; KINESIOTHERAPY; MALE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; VESTIBULAR MIGRAINE; BLOOD; ENZYMOLOGY; EXERCISE; MIDDLE AGED; MIGRAINE DISORDERS; PHYSIOLOGY; SIGNAL TRANSDUCTION;

CYCLOOXYGENASE 2; CYTOKINES; DIZZINESS; EXERCISE; EXERCISE THERAPY; FEMALE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; MIGRAINE DISORDERS; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84937037215     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2015.06.005     Document Type: Article

References (38)

1. Aggarwal B.B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 2003, 3:745-756.
2. Aggarwal B.B. Nuclear factor-kappaB: the enemy within. Cancer Cell 2004, 6:203-208.
3. Calabrese V., Cornelius C., Maiolino L., Luca M., Chiaramonte R., Toscano M.A., Serra A. Oxidative stress, redox homeostasis and cellular stress response in Meniere's disease: role of vitagenes. Neurochem. Res. 2010, 35:2208-2217.
4. Chen P.Y., Hsieh W.L., Wei S.H., Kao C.L. Interactive wiimote gaze stabilization exercise training system for patients with vestibular hypofunction. J. Neuroeng. Rehabil. 2012, 9:77.
5. Chu Y.T., Cheng L. Vertigo and dizziness. Acta Neurol. Taiwan. 2007, 16:50-60.
6. Chun K.S., Surh Y.J. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. Biochem. Pharmacol. 2004, 68:1089-1100.
7. DiDonato J.A., Mercurio F., Karin M. NF-kappaB and the link between inflammation and cancer. Immunol. Rev. 2012, 246:379-400.
8. Dieterich M., Eckhardt-Henn A. Neurological and somatoform vertigo syndromes. Der Nervenarzt 2004, 75:281-302.
9. Emeis J.J., Kooistra T. Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells. J. Exp. Med. 1986, 163:1260-1266.
10. Frohman E.M., Zhang H., Dewey R.B., Hawker K.S., Racke M.K., Frohman T.C. Vertigo in MS: utility of positional and particle repositioning maneuvers. Neurology 2000, 55:1566-1569.
11. Furman J.M., Marcus D.A., Balaban C.D. Vestibular migraine: clinical aspects and pathophysiology. Lancet Neurol. 2013, 12:706-715.
12. Gaur V., Kumar A. Effect of nonselective and selective COX-2 inhibitors on memory dysfunction, glutathione system, and tumor necrosis factor alpha level against cerebral ischemia reperfusion injury. Drug Chem. Toxicol. 2012, 35:218-224.
13. Guzik T.J., Mangalat D., Korbut R. Adipocytokines - novel link between inflammation and vascular function?. J. Physiol. Pharmacol. 2006, 57:505-528.
14. Hassan-Zahraee M., Tran E.H., Bourbonniere L., Owens T. Elevated interferon-gamma in CNS inflammatory disease: a potential complication for bone marrow reconstitution in MS. J. Neuroimmunol. 2000, 108:40-44.
15. Ikeda-Matsuo Y. The role of prostaglandin E2 in stroke-reperfusion injury Yakugaku zasshi. J. Pharm. Soc. Jpn. 2013, 133:947-954.
16. Imamura K., Takeshima T., Fusayasu E., Nakashima K. Increased plasma matrix metalloproteinase-9 levels in migraineurs. Headache 2008, 48:135-139.
17. Iwaki T., Urano T., Umemura K. PAI-1, progress in understanding the clinical problem and its aetiology. Br. J. Haematol. 2012, 157:291-298.
18. Kaiser E., Chiba P., Zaky K. Phospholipases in biology and medicine. Clin. Biochem. 1990, 23:349-370.
19. Kao C.L., Chen L.K., Chern C.M., Hsu L.C., Chen C.C., Hwang S.J. Rehabilitation outcome in home-based versus supervised exercise programs for chronically dizzy patients. Arch. Gerontol. Geriatr. 2010, 51:264-267.
20. Kao C.L., Tsai K.L., Cheng Y.Y., Kuo C.H., Lee S.D., Chan R.C. Vestibular rehabilitation ameliorates chronic dizziness through the SIRT1 axis. Front. Aging Neurosci. 2014, 6:27.
21. Karatas M. Central vertigo and dizziness epidemiology, differential diagnosis, and common causes. Neurologist 2008, 14:355-364.
22. Kassner S.S., Schottler S., Bonaterra G.A., Stern-Straeter J., Hormann K., Kinscherf R., Gossler U.R. Proinflammatory activation of peripheral blood mononuclear cells in patients with vestibular neuritis. Audiology Neuro-otol. 2011, 16:242-247.
23. Kroenke K., Hoffman R.M., Einstadter D. How common are various causes of dizziness? A critical review. South. Med. J. 2000, 93:160-167.
24. Kumar A.P., Ryan C., Cordy V., Reynolds W.F. Inducible nitric oxide synthase expression is inhibited by myeloperoxidase. Nitric oxide 2005, 13:42-53.
25. Lee H., Sohn S.I., Jung D.K., Cho Y.W., Lim J.G., Yi S.D., Yi H.A. Migraine and isolated recurrent vertigo of unknown cause. Neurol. Res. 2002, 24:663-665.
26. Lempert T., Olesen J., Furman J., Waterston J., Seemungal B., Carey J., Bisdorff A., Versino M., Evers S., Newman-Toker D. Vestibular migraine: diagnostic criteria. J. Vestibular Res. 2012, 22:167-172.
27. Lim C.S., Shalhoub J., Gohel M.S., Shepherd A.C., Davies A.H. Matrix metalloproteinases in vascular disease-a potential therapeutic target?. Curr. Vasc. Pharmacol. 2010, 8:75-85.
28. Maes M., Lin A.H., Delmeire L., Van Gastel A., Kenis G., De Jongh R., Bosmans E. Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biol. Psychiatry 1999, 45:833-839.
29. Niehaus W.G., Samuelsson B. Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur. J. Biochem./FEBS 1968, 6:126-130.
30. Nuvoli B., Galati R. Cyclooxygenase-2, epidermal growth factor receptor, and aromatase signaling in inflammation and mesothelioma. Mol. Cancer Ther. 2013, 12:844-852.
31. Perini F., D'Andrea G., Galloni E., Pignatelli F., Billo G., Alba S., Bussone G., Toso V. Plasma cytokine levels in migraineurs and controls. Headache 2005, 45:926-931.
32. Picchi A., Gao X., Belmadani S., Potter B.J., Focardi M., Chilian W.M., Zhang C. Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome. Circ. Res. 2006, 99:69-77.
33. Raponi G., Alpini D., Volonte S., Capobianco S., Cesarani A. The role of free radicals and plasmatic antioxidant in Meniere's syndrome. Int. Tinnitus J. 2003, 9:104-108.
34. Reid S.A., Rivett D.A. Manual therapy treatment of cervicogenic dizziness: a systematic review. Manual Ther. 2005, 10:4-13.
35. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:7240-7244.
36. Spivak B., Shohat B., Mester R., Avraham S., Gil-Ad I., Bleich A., Valevski A., Weizman A. Elevated levels of serum interleukin-1 beta in combat-related posttraumatic stress disorder. Biol. Psychiatry 1997, 42:345-348.
37. Takumida M., Anniko M., Ohtani M. Radical scavengers for Meniere's disease after failure of conventional therapy: a pilot study. Acta oto-laryngologica 2003, 123:697-703.
38. Tran E.H., Prince E.N., Owens T. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines. J. Immunol. 2000, 164:2759-2768.